Event Details
The dream of fending off old age is not new. Given the global aging of the population, developing interventions that preserve health in old age and postpone the onset of age-related diseases is more important than ever. Age-related conditions are the leading causes of death and health-care costs.
It is now possible to retard aging in animal models. Various genetic, dietary, and pharmacological interventions have been shown to increase lifespan, in some cases dramatically (tenfold is the current record), in short-lived model organisms. Importantly, life-extending interventions not only increase longevity but can retard the onset of age-related diseases, resulting in the extension of healthspan (i.e., the length of time one lives in good health).
Approaches to enhancing healthspan range from drug discovery efforts to big-data methods and direct-to-consumer (DTC) strategies. Challenges of commercialization include reliance on findings from short-lived model organisms, poor biological understanding of aging, and hurdles in performing clinical trials for aging. Yet if even one company succeeds, the social and financial impact will be huge.
Join us for this exciting forum where we will review how entrepreneurs may approach the most promising advances in healthspan biotech, how entrepreneurs may approach these opportunities, the path to financing, and the resources in Southern California.
- Saturday — October 13, 2018
9:00AM - 11:30AM - Cahill Astronomy and Astrophysics Center, Caltech
1216 E California Blvd
Pasadena, CA 91125
View Map
The Organizer
Caltech
Scientists, engineers, and—above all—innovative thinkers, Caltech scholars thrive in an environment of intellectual creativity and freedom. Our faculty, alumni, and trustees have been recognized with top national and international honors and the world's most prestigious prizes for their bold scientific explorations and inspired collaborations.